Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yea but .50 we get a break from this username for 30 days. You can continue using LC.
It wasn’t zero upfront. Learn to read.
“The terms of the Roswell license include standard provisions for an upfront license fee…”
Great, so we won’t see you for a month once it does.
Read a little more carefully. There is an upfront fee.
“The terms of the Roswell license include standard provisions for an upfront license fee”
There aren’t a large amount of suitors for this type of tech. NWBO is uniquely positioned because they already inlicensed previous work. The cost goes down when there aren’t a bunch of buyers. You confusing cost vs value.
“Taken together, the Company believes that the two portfolios comprise a whole that is greater than the sum of its parts and offer compelling synergies with the Company’s own portfolio.”
Still can’t answer my question? Just like your claim she makes 4x the salary of the average biotech CEO. You and LC can continue making your BS claims. Just remember to sign onto the right account when you’re making them.
You completely missed the question. I don’t need a history lesson. The application is submitted. What is she currently doing that is delaying the application from being processed?
How are they slow walking an application that has been submitted? I would love to hear that explanation.
That’s what you fail to understand. Profits and revenue come after approval. If this thing doesn’t get approval, this goes to zero. If it does, price appreciates by at least 5x from today’s prices. Advent, options and all that other crap you keep harping on don’t matter. There’s asymmetric reward to risk.
I don’t care to counter any of it because it just doesn’t matter. You keep harping on all this junk to try to convince investors that it matters. I don’t care if LP gets rich. I don’t care about Advent or options. I care if my investment pays off. With approval, the stock price will appreciate. Application has been filed. It’s a waiting game.
I don’t own the stock, I don’t short the stock. I’m just a troll that has nothing better to do. Good to know where you stand. Carry on.
Synthetic control arms are formed by carefully selecting patients from historical clinical trials to match the demographic and disease characteristics of the patients treated with the new investigational product. They have great potential to enhance single arm trials and enable more efficient randomized clinical trials in indications where the standard of care therapy is impracticable or unacceptable to patients.
This is exactly what the JAMA article did. The information they do have is sufficient for approval. Why would you think Medicenna would have access to differ information from historical trials than NWBO. They don’t have individual charts is what LL was saying. You don’t need that for approval and Medicenna’s approval of the trial is proof.
There is nothing that says they have to meet demand but they are required to show that they are able to manufacture the product for commercial sale. Advent would not qualify as a manufacturer unless the facility gets licensed by the FDA. From a resource standpoint, I believe a BLA is out of their reach. With an approval from the MHRA, I believe partnerships will be made and the Company will have financial and other resources made available to them to continue seeking other approvals. We should have a good update on EDEN at the ASM. It is likely the BLA will incorporate EDEN making the manufacturing component of the BLA less complex and much easier to create domestic manufacturing.
Is anyone else tracking the available shares to short? About 7.5 million were added a couple days ago and they disappeared this morning. Seems a little strange.
About 7.5 million more shares available to short as of this morning. 300k taken out today.
What does the derivative suit have to do with approval? 2 separate matters entirely. I’ve been practicing for close to 20 years. I’m giving my opinion on how I see the shareholder vote on the options awards affecting the legal case. I’m pretty sure you don’t have the same background as I do so maybe you’re the one full of shit. I’m invested heavily in this stock and would love to see approval tomorrow.
What’s bullshit? I’m entitled to my opinion.
The quickest path forward would probably be to cancel the options which would make this case moot. I’m not 100% sure what would happen with the fee award but I’m sure that would be cheaper than protracted litigation. If shareholders are going to approve the options now, no reason they wouldn’t approve them later.
I don’t believe a yes vote will completely get rid of the case. As of now, the directors deny the options are a “true up”. In order to win on a ratification defense, the shareholders would have to make an informed decision based on the case allegations. In this case, the proxy should say that the options are a “true up”and the shareholders agree to give the “true up”, regardless of whether or not it’s true. The proxy fails to do that so I don’t believe a ratification defense can be accomplished by a yes vote.
Then if that’s the case, the warrants being a means to maintain control is a moot point. That’s how this whole discussion was started. It proves my point that the warrants have no bearing on control and your claim is bullshit.
As I told you before, I’m not Hoff. I’m not paid a dime. However, I am heavily invested so I find it worthwhile to combat the crap that you and the other clowns allege.
I lost because you said I did? You don’t even understand the things you post. Try finding relevant content that actually supports your position idiot.
You are so dumb you have no idea what that article means. It states that a minority shareholder can be deemed a controlling shareholder for purposes of adherence to fiduciary duties similar to a director. Read the implications section you idiot. It has NOTHING to do with actual control. Keep digging yourself in a bigger hole you moron.
Implications of Controlling Stockholder Status
When a controlling stockholder is involved in a transaction, there are two primary consequences: imposition of fiduciary duties and enhanced transaction scrutiny. Under Delaware law, stockholders typically do not owe fiduciary duties.19 However, because a controlling stockholder effectively controls the company,20 a controlling stockholder assumes fiduciary duties similar to those of a director on the board.
https://harvardlawreview.org/print/vol-133/controller-confusion-realigning-controlling-stockholders-and-controlled-boards/
Yes, controlling vote is over 50% moron. That is why your claim is complete bullshit. Go figure out something else to gaslight us about.
No you idiot. You need a majority of the outstanding voting shares to have control. They won’t have over 50% even after exercising their options. Thats why your claim about control is complete bullshit. Do you try being this dumb or does it come naturally?
It’s not a belief moron. It’s literally in the document you quoted. Why do you think retail gets notified? That’s not how it works moron. Also, even if all the options are exercised they won’t have 51% of the outstanding shares to control the company. Everything you say makes you look dumber and dumber. Continue to outdo yourself.
Truth hurts I guess
Thanks for proving my point moron. The whole reason they are not beneficially owned is because the exercise rights are over 60 days under Rule 13d. The law deems these types of options non-beneficial because they confer no shareholder rights including voting rights. So tell me again how you believe they are used for control when they carry no voting rights and the statute confirms this?
Want to tell me how many options they’ve actually exercised to maintain control moron?
You’re the dummy if you anticipated approval a few months after data lock. It’s not the Company’s fault that you had unrealistic expectations.
Really? The MAA was filed 4 years ago? Do you want to try using your brain prior to posting?
In what world do options give you control if they’re not exercised? The options get restructured along with the equities. 12 years here and you become dumber and dumber
The fact that you think I can give you a date makes you a bigger moron than I thought. The decision will come when the MHRA decides to issue it. NWBO has no control over that date. Should be within the next few months. You can then come on here and start complaining about why there is no BLA yet.
I understand your position. I voted yes. I figure this will either go close to zero without approval or will be in dollar land with approval. If they get this approved, they can get their options. If they don’t, it’s a moot point as those options will be essentially worthless.
Great. When they get MHRA approval, I’ll remind you that you were wrong all along and you can leave. Shouldn’t be longer than a few months.
Whether they win or lose is irrelevant. The point is a law firm took this case and filed it in federal court. This is not some ruse to fool shareholders as you claim. Filing frivolous lawsuits are sanctionable. I know it was taken on a contingency and I know the lawsuit against them was also taken on contingency because that is standard practice in the industry. People like you that have no legal experience want to come on here and sow doubt for no reason. Also, why are you so concerned about the true up lawsuit? They are just receiving options. If this company is worth zero, those options expire worthless. The problem is you can’t keep your story straight. This stock should hit .50 this week. That will be proof you don’t have a clue about anything. Take a 30 day break, get a real job and maybe start buying some stock. You’ll thank me later.
And unrelated 3rd party law firms take spoofing cases on contingency to add credibility to the scam? You should change your name to clownsuit
It’s the same one that’s used in the phase 1 study. Here is the clinical study agreement where it says the investigator (LL) will be manufacture DCVax at UCLA. You keep making up lies.
https://www.sec.gov/Archives/edgar/data/1072379/000095012406001956/v16023exv10w35.htm
The theory clown takes breaks from his day job at the circus to post here. He needs some new material.
You said she is paid 4x the amount of biotech CEOs. That means she getting that amount today, not in 2020. She also had that 1 year with exorbitant compensation. She was paid significantly less than other similar CEOs in all other years AND is paid less today. Are you too dumb to realize that?
PDS Biotechnology-Market Cap $106 Million
CEO Salary $580K Bonus $255K Total Compensation $5 Million
Cellectar Biosciences-Market Cap $112 Million
CEO Salary $600K Bonus $450K Total Compensation $1,965,140
Actinium Pharmaceuticals-Market Cap $253 Million
CEO Salary 705K Bonus $500K Total Compensation $4,705,000
Look at some comparable compensation you clown. These are all microcap biotechs. You have no idea what you're talking about. Unlike you, I back up what I say with evidence. That is what us "lawyer boys" do. You basement boys just like to rant.